Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
176,523,077
-
Share change
-
+793,991
-
Total reported value
-
$27,035,640,674
-
Put/Call ratio
-
91%
-
Price per share
-
$153.17
-
Number of holders
-
857
-
Value change
-
+$77,310,542
-
Number of buys
-
313
-
Number of sells
-
415
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2018
As of 31 Dec 2018,
Edwards Lifesciences Corp - Common Stock (EW) was held by
857 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
176,523,077 shares.
The largest 10 holders included
Vanguard Group Inc, BlackRock Inc., STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Bank of New York Mellon Corp, ALLIANCEBERNSTEIN L.P., JENNISON ASSOCIATES LLC, and Capital Research Global Investors.
This page lists
861
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.